These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11120800)

  • 1. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
    Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
    J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
    Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
    J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL.
    McAdam AJ; Gewurz BE; Farkash EA; Sharpe AH
    J Immunol; 2000 Sep; 165(6):3088-93. PubMed ID: 10975820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.
    Barouch DH; Santra S; Tenner-Racz K; Racz P; Kuroda MJ; Schmitz JE; Jackson SS; Lifton MA; Freed DC; Perry HC; Davies ME; Shiver JW; Letvin NL
    J Immunol; 2002 Jan; 168(2):562-8. PubMed ID: 11777947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86.
    Agadjanyan MG; Chattergoon MA; Holterman MJ; Monzavi-Karbassi B; Kim JJ; Dentchev T; Wilson D; Ayyavoo V; Montaner LJ; Kieber-Emmons T; Sekaly RP; Weiner DB
    J Immunol; 2003 Oct; 171(8):4311-9. PubMed ID: 14530356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.
    Cho HJ; Hayashi T; Datta SK; Takabayashi K; Van Uden JH; Horner A; Corr M; Raz E
    J Immunol; 2002 May; 168(10):4907-13. PubMed ID: 11994440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration.
    Barouch DH; Santra S; Steenbeke TD; Zheng XX; Perry HC; Davies ME; Freed DC; Craiu A; Strom TB; Shiver JW; Letvin NL
    J Immunol; 1998 Aug; 161(4):1875-82. PubMed ID: 9712056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ag85B of mycobacteria elicits effective CTL responses through activation of robust Th1 immunity as a novel adjuvant in DNA vaccine.
    Takamura S; Matsuo K; Takebe Y; Yasutomi Y
    J Immunol; 2005 Aug; 175(4):2541-7. PubMed ID: 16081827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL.
    Prilliman KR; Lemmens EE; Palioungas G; Wolfe TG; Allison JP; Sharpe AH; Schoenberger SP
    J Immunol; 2002 Oct; 169(8):4094-7. PubMed ID: 12370335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination.
    Santra S; Barouch DH; Sharpe AH; Letvin NL
    Eur J Immunol; 2000 Sep; 30(9):2650-9. PubMed ID: 11009099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo.
    Seaman MS; Peyerl FW; Jackson SS; Lifton MA; Gorgone DA; Schmitz JE; Letvin NL
    J Virol; 2004 Jan; 78(1):206-15. PubMed ID: 14671102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine.
    Cusi MG; Del Vecchio MT; Terrosi C; Savellini GG; Di Genova G; La Placa M; Fallarino F; Moser C; Cardone C; Giorgi G; Francini G; Correale P
    J Immunol; 2005 Jun; 174(11):7210-6. PubMed ID: 15905566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.
    Kim JJ; Nottingham LK; Wilson DM; Bagarazzi ML; Tsai A; Morrison LD; Javadian A; Chalian AA; Agadjanyan MG; Weiner DB
    Vaccine; 1998 Nov; 16(19):1828-35. PubMed ID: 9795388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.
    Kojima Y; Xin KQ; Ooki T; Hamajima K; Oikawa T; Shinoda K; Ozaki T; Hoshino Y; Jounai N; Nakazawa M; Klinman D; Okuda K
    Vaccine; 2002 Jul; 20(23-24):2857-65. PubMed ID: 12126895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M cell DNA vaccination for CTL immunity to HIV.
    Wang X; Hone DM; Haddad A; Shata MT; Pascual DW
    J Immunol; 2003 Nov; 171(9):4717-25. PubMed ID: 14568947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costimulation provided by DNA immunization enhances antitumor immunity.
    Corr M; Tighe H; Lee D; Dudler J; Trieu M; Brinson DC; Carson DA
    J Immunol; 1997 Nov; 159(10):4999-5004. PubMed ID: 9366427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen.
    Fomsgaard A; Nielsen HV; Bryder K; Nielsen C; Machuca R; Bruun L; Hansen J; Buus S
    Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.